http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2533873-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eccd894c99fea2d1c0c8735872bb2309 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 |
| filingDate | 2008-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c43fdaf4b1ce505e9c56f92e6b4f336 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3353ef74f5b55b7199a59c2820cfceac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f51d4627d52c0ea7da8ee332e9a19a0f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04073078ac120b818440ed5e5c968d10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b2732c56900db232e918d7548b95ddb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa724e24363c73cfdd312154837e1ddc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1e9078a30d1e5c0ccf05ea611776a71 |
| publicationDate | 2015-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2533873-T3 |
| titleOfInvention | Derivatives of 6- (pyrrolopyridinyl) -pyrimidin-2-yl-amine and its use for the treatment of cancer and AIDS |
| abstract | Compounds of formula I ** Formula ** where R1 represents H, A or - [C (R5) 2] nAr, R2 represents A, - [C (R5) 2] nAr, - [C (R5) 2] nHet, - [C (R5) 2] ncycloalkyl, - [C (R5) 2] nOR5, - [C (R5) 2] nN (R5) 2 or - [C (R5) 2] nCOOR5, R3 represents H, A, Hal, CN, - [C (R5) 2] nAr, - [C (R5) 2] nHet or - [C (R5) 2] ncycloalkyl or - [C (R5) 2] nN (R5) 2, R4 represents H, A, - [C (R5) 2] nAr, - [C (R5) 2] nHet or - [C (R5) 2] ncycloalkyl, R5 represents H or alkyl with 1-6 atoms of C, A represents unbranched or branched alkyl with 1-10 C atoms, where one or two CH2 groups can be replaced by O or S atoms and / or by -CH> = CH- groups, and / or also 1-7 H atoms can be replaced by F, Cycloalkyl represents cyclic alkyl with 3-7 C atoms, which additionally can be substituted by alkyl with 1-6 C atoms, Hal represents F, Cl, Br or I, Ar represents phenyl unsubstituted or mono-, di-, or tri-substituted by Hal, A, OR5, N (R5) 2, NO2, CN, COOR5, CON (R5) 2, NR5COA, NR5SO2A, COR5, SO2N (R5) 2 and / or by S (O) pA, Het represents a mono- or bi-nuclear, saturated, unsaturated or aromatic heterocycle with 1 to 4 atoms of N and / or O and / or S, which is unsubstituted or mono-, di- or tri- replaced by Hal, A, OR5, N (R5) 2, NO2, CN, COOR5, CON (R5) 2, NR5COA, NR5SO2A, COR5, SO2NR520, S (O) pA and / or> = O (carbonyl oxygen) , n represents 0, 1, 2, 3 or 4. p represents 0, 1 or 2, as well as its pharmaceutically usable solvates, salts, tautomers and stereoisomers, including mixtures thereof in any proportion. |
| priorityDate | 2007-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 195.